Adam Bayes

Dr Bayes is a clinical academic psychiatrist with a special interest in mood disorders (depressive and bipolar conditions) including their diagnosis, classification and treatment – with the latter focusing on interventional psychiatry (e.g. rapidly acting antidepressants) and novel neurostimulation (transcranial magnetic stimulation; TMS). Adam works at the interface of research and clinical application, and has an interest in developing models of care most recently establishing the BDI Ketamine Treatment Program which arose out of a clinical trial. In addition to spending half of his time managing patients as a psychiatrist, he is actively engaged in teaching and mentoring medical students, psychiatry registrars, higher degree researchers as well as contributing to treatment guidelines and conducting workshops for psychiatrists and GPs.